Friday 6 November 2026 Export LMAT’s income statement to Excel — free account

LeMaitre Vascular, Inc.

LMAT Healthcare Medical Instruments & Supplies

LeMaitre Vascular, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $249.6 million, up 13.5% from fiscal 2024.

Revenue: +11.3%
EPS: −14.3%
Free cash flow: −25.8%
Total debt: +0.53%

Quarter to September 2026, against a year earlier

82.87 5.05 −5.74%

Follow LMAT

Alert me

Market cap: $1.9B
P/E: 29.7×
Fwd P/E: 28.2×
Dividend yield: 1.15%
F-score: 6/9
Altman Z: 6.99
Beneish M: −2.61
Dividend safety: 93/100

Overview

LeMaitre Vascular, Inc. (LMAT) P/E ratio

Alert me on P/E ratio

As of 5 November 2026, LeMaitre Vascular, Inc. (LMAT) trades at a P/E ratio of 29.7×. Over the past ten years it has ranged from 19.0× (January 2019) to 72.6× (June 2023); the current reading is higher than 12% of that period. That is in line with the Medical Instruments & Supplies industry median of 30.3× and above the Healthcare sector median of 25.2×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/LMAT/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="LeMaitre Vascular, Inc. P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/LMAT/metrics/pe-ratio">LeMaitre Vascular, Inc. (LMAT) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	31.7×	(32.27%)
FY2024	46.8×	11.34%
FY2023	42.0×	(12.16%)
FY2022	47.8×	20.91%
FY2021	39.6×	2.54%
FY2020	38.6×	(3.44%)
FY2019	39.9×	99.38%
FY2018	20.0×	(42.06%)
FY2017	34.6×	(21.88%)
FY2016	44.3×	12.90%

Period	P/E ratio	Change
Sep 2026	29.6×	(10.54%)
Jun 2026	33.1×	(16.34%)
Mar 2026	39.6×	24.86%
Dec 2025	31.7×	(14.20%)
43 more quarters	Free account

Against its own ten years

Low 19.0× High 72.6×

Ten-year median 39.0×

Current reading's percentile 12

Company	P/E ratio
PLSE Pulse Biosciences, Inc compare	n/m
KMTS Kestra Medical Technologies, Ltd. compare	n/m
STAA STAAR Surgical Company compare	n/m
AZTA Azenta, Inc. compare	n/m
XRAY DENTSPLY SIRONA Inc. compare	n/m
STVN Stevanato Group S.p.A. compare	22.4×
LMAT LeMaitre Vascular, Inc.	29.7×
ATRC AtriCure, Inc. compare	199×
WRBY Warby Parker Inc. compare	434×
Medical Instruments & Supplies industry median	30.3×
Healthcare sector median	25.2×
Market median	17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

LeMaitre Vascular, Inc. (LMAT) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on LMAT

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on LMAT

Stockrow Weekly